Chemical Component Summary | |
|---|---|
| Name | AZD5991 |
| Formula | C35 H34 Cl N5 O3 S2 |
| Molecular Weight | 672.259 |
| Type | NON-POLYMER |
| Isomeric SMILES | Cc1c-2c(nn1C)CSCc3cc(n(n3)C)CSc4cc5ccccc5c(c4)OCCCc6c7ccc(c2c7n(c6C(=O)O)C)Cl |
| InChI | InChI=1S/C35H34ClN5O3S2/c1-20-31-29(38-40(20)3)19-45-17-22-15-23(41(4)37-22)18-46-24-14-21-8-5-6-9-25(21)30(16-24)44-13-7-10-26-27-11-12-28(36)32(31)33(27)39(2)34(26)35(42)43/h5-6,8-9,11-12,14-16H,7,10,13,17-19H2,1-4H3,(H,42,43) |
| InChIKey | KBQCEQAXHPIRTF-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 80 |
| Chiral Atom Count | 0 |
| Bond Count | 86 |
| Aromatic Bond Count | 31 |
Drug Info: DrugBank
| DrugBank ID | DB14792 |
|---|---|
| Name | AZD-5991 |
| Groups | investigational |
| Description | AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.). |
| Synonyms | AZD-5991 |
| Categories | Antineoplastic Agents |
| CAS number | 2143010-83-5 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL4297482 |
| PubChem | 131634760 |
| ChEMBL | CHEMBL4297482 |
